Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$348K Buy
2,711
+28
+1% +$3.28K 0.12% 120
2026
Q1
$323K Buy
2,683
+75
+3% +$8.66K 0.12% 115
2025
Q4
$275K Buy
2,608
+73
+3% +$6.85K 0.11% 141
2025
Q3
$213K Buy
+2,535
New +$209K 0.1% 159
2025
Q2
Sell
-2,893
Closed -$260K 149
2025
Q1
$260K Sell
2,893
-343
-11% -$32K 0.15% 112
2024
Q4
$322K Sell
3,236
-128
-4% -$13.2K 0.18% 89
2024
Q3
$382K Sell
3,364
-68
-2% -$8.08K 0.19% 74
2024
Q2
$425K Buy
3,432
+191
+6% +$24.6K 0.21% 61
2024
Q1
$428K Buy
3,241
+216
+7% +$26.6K 0.2% 62
2023
Q4
$330K Buy
+3,025
New +$314K 0.17% 76

Other funds holding MRK

Traveka Wealth's MRK Position: Q2 2026 in Review

Traveka Wealth increased its Merck (MRK) stake by 1% in Q2 2026, buying an estimated $3.28K and bringing the position to 2,711 shares worth $348K. The position accounts for 0.12% of the portfolio, ranked #120.

Traveka Wealth first reported a position in MRK in Q4 2023 and has held it in 10 quarters since. The position peaked at $428K in Q1 2024. 1,981 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Traveka Wealth held 2,711 shares of Merck worth $348K as of Q2 2026.
  • Traveka Wealth bought 28 Merck shares in Q2 2026, an estimated $3.28K.
  • Merck made up 0.12% of Traveka Wealth's portfolio in Q2 2026, its #120 holding.
  • Traveka Wealth first reported a position in Merck in Q4 2023 and has held it in 10 quarters since.
  • Traveka Wealth's Merck position peaked at $428K in Q1 2024.
  • 1,981 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Traveka Wealth's 13F filing for Q2 2026, filed 21 Jul 2026.